Active Immunity Is The Outcome Of The Immune System Producin

Active Immunity Is The Outcome Of The Immune System Producing Antibodi

Active immunity is the outcome of the immune system producing antibodies against a disease after being exposed to the disease organism. It can be acquired naturally through infection or artificially via vaccination. When antibodies against a disease are supplied to a person rather than being produced by their own immune system, passive immunity is established. For example, an individual who recovers from measles develops active immunity and becomes immune to further infections. Conversely, when a mother passes antibodies to her fetus through the placenta or to her child through breastfeeding, passive immunity is conferred. Proteins called immunoglobulins are produced by plasma cells and lymphocytes and are essential to immune defense. There are five classes of immunoglobulins: IgM, IgG, IgA, IgE, and IgD, each with specific functions. IgM is primarily produced during the initial immune response to pathogens, whereas IgG is predominant in secondary responses and can cross the placenta to protect the fetus. IgA is the main antibody in secretions such as saliva, tears, and mucous membranes, providing localized immunity at mucosal surfaces. IgE interacts with high-affinity receptors on mast cells and basophils, playing a vital role in allergic reactions and protection against parasites. IgD’s role remains less well-understood but may be involved in lymphocyte activation and differentiation (Justiz et al., 2022; CDC, 2021).

Paper For Above instruction

Understanding the immune system’s mechanisms of active and passive immunity is fundamental in immunology and critical for vaccine development, disease prevention, and clinical management of infectious diseases. Active immunity, whether acquired naturally or artificially, enables the body to recognize and combat specific pathogens effectively upon re-exposure. This form of immunity is characterized by the production of memory cells, which provide long-lasting protection. Vaccination, for instance, introduces an antigen to stimulate active immunity without causing disease, thus priming the immune system to respond more rapidly and robustly when faced with the actual pathogen. Naturally acquired active immunity occurs when an individual contracts an illness and subsequently develops antibodies, such as after recovering from measles (CDC, 2021).

In contrast, passive immunity provides immediate but temporary protection by transferring pre-formed antibodies from another source, such as maternal antibodies passed through the placenta or breast milk. Passive immunity is often utilized in emergency situations, like administering immunoglobulin shots after exposure to rabies or hepatitis B. The body's immune response involves a variety of immunoglobulin classes, each with unique roles. IgM is produced early in infection as part of the primary immune response, serving as an initial defense. IgG, dominating secondary responses, is highly effective in neutralizing pathogens and can traverse the placenta to protect the fetus, conferring passive neonatal immunity. IgA is crucial for mucosal immunity, preventing pathogen adherence and invasion at mucous membranes in the respiratory, gastrointestinal, and urogenital tracts (Justiz et al., 2022).

IgE plays a pivotal role in defending against parasitic infections, particularly helminths, and mediates allergic responses by binding to Fc receptors on mast cells and basophils, leading to the release of histamine and other mediators. While the function of IgD remains not fully understood, it is believed to assist in B cell activation and differentiation during initial immune responses (Justiz et al., 2022). These various immunoglobulin classes orchestrate a complex defense network that allows humans to effectively respond to diverse pathogens.

In summary, active immunity provides a durable defense mechanism through the generation of immunologic memory, whereas passive immunity offers rapid but short-term protection by directly supplying antibodies. Both forms are essential in managing infectious diseases, with vaccination serving as a key strategy to induce lasting immunity and passive antibody transfer used in specific clinical circumstances. The understanding of immunoglobulin functions supports advancements in immunotherapy, vaccine design, and infectious disease control (CDC, 2021; Justiz et al., 2022).

References

• Centers for Disease Control and Prevention (CDC). (2021, September 24). Types of immunity to a disease. Retrieved November 6, 2022, from https://www.cdc.gov
• Justiz Vaillant, A. A., Jamal, Z., Patel, P., et al. (2022). Immunoglobulin. In StatPearls. Treasure Island (FL): StatPearls Publishing.
• Huether, S., & McCance, K. (2014). Pathophysiology: The Biological Basis for Disease in Adults and Children (7th ed.). Elsevier.
• Oka, S., Ikeda, K., Takano, M., et al. (2020). Pathogenesis, clinical course, and recent issues in HIV-1-infected Japanese hemophiliacs: a three-decade follow-up. Global Health & Medicine, 2(1), 9-17.
• Saag, M. S., Gandhi, R. T., Hoy, J. F., et al. (2020). Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations. JAMA, 324(16), 1651-1669.
• Showa, S. P., Nyabadza, F., & Hove-Musekwa, S. D. (2019). On the efficiency of HIV transmission: Insights through discrete time HIV models. PLoS One, 14(9), e0222334.
• Mayo Foundation for Medical Education and Research. (2021, July 8). Chronic stress puts your health at risk. Mayo Clinic. Retrieved November 7, 2022, from https://www.mayoclinic.org
• Tsigos, C., Kyrou, I., Kassi, E., et al. (2020). Stress: Endocrine Physiology and Pathophysiology. In Feingold KR, Anawalt B, Boyce A, et al. (Eds.), Endotext. South Dartmouth, MA: MDText.com.